#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA707922	F	Concentration required for 50% inhibition of cell growth of L1210 leukemic cell lines in mouse.	Mus musculus	8	ALA1125887	cell-based format	Scientific Literature
2.	ALA837959	F	Cytotoxic concentration against bovine viral diarrhea virus (BVDV) in MDBK cells	Bos taurus	4	ALA1141159	cell-based format	Scientific Literature
3.	ALA836693	F	Cytotoxic concentration against HCV replication RNA levels in Huh7 cells determined by HCV replicon assay	Homo sapiens	4	ALA1141159	cell-based format	Scientific Literature
4.	ALA833164	F	Effective concentration required to reduce HCV replication RNA levels in Huh7 cells by 90% determined by HCV replicon assay	Homo sapiens	4	ALA1141159	cell-based format	Scientific Literature
5.	ALA833307	F	Effective concentration required to reduce cytopathic effects caused by bovine viral diarrhea virus (BVDV) in MDBK cells by 90%	Bos taurus	4	ALA1141159	cell-based format	Scientific Literature
6.	ALA911146	P	Aqueous solubility of the compound		2	ALA1137330	small-molecule physicochemical format	Scientific Literature
7.	ALA911147	P	Distribution coefficient, log P of the compound		2	ALA1137330	small-molecule physicochemical format	Scientific Literature
8.	ALA911148	P	Chemical stability at pH 4.5		1	ALA1137330	small-molecule physicochemical format	Scientific Literature
9.	ALA911149	P	Chemical stability at pH 7.2		1	ALA1137330	small-molecule physicochemical format	Scientific Literature
10.	ALA911178	A	Protein binding in rat plasma at 20 uM	Rattus norvegicus	2	ALA1137330	cell-free format	Scientific Literature
11.	ALA910542	A	Apparent oral bioavailability in jugular vein cannulated Sprague-Dawley rat at 100 mg/kg, po administered as prodrug	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
12.	ALA910544	A	Cmax in jugular vein cannulated Sprague-Dawley rat at 100 mg/kg, po administered as prodrug	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
13.	ALA910545	A	Terminal half life in jugular vein cannulated Sprague-Dawley rat at 100 mg/kg, po administered as prodrug	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
14.	ALA910546	A	Tmax in jugular vein cannulated Sprague-Dawley rat at 100 mg/kg, po administered as prodrug	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
15.	ALA910547	A	AUC(0-t) in jugular vein cannulated Sprague-Dawley rat at 100 mg/kg, po administered as prodrug	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
16.	ALA910548	A	Cmax in Sprague-Dawley rat after 15 days at 60 mg/kg/day, iv	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
17.	ALA910549	A	AUC in Sprague-Dawley rat after 15 days at 60 mg/kg/day, iv	Rattus norvegicus	1	ALA1137330	organism-based format	Scientific Literature
18.	ALA912423	P	Chemical stability at pH 1.2		1	ALA1137330	small-molecule physicochemical format	Scientific Literature
19.	ALA910985	B	Activity of human dCK expressed in HepG2 cells assessed as phosphorylation by coupled enzyme assay	Homo sapiens	7	ALA1142170	cell-based format	Scientific Literature
20.	ALA910984	B	Ratio of Kcat to Km for human dCK expressed in HepG2 cells	Homo sapiens	7	ALA1142170	cell-based format	Scientific Literature